The delivery of macromolecular drugs (DNA, RNAi) to the heart of the cell may represent a difficult task for many research and development programs.

We all know the drawbacks of existing methods including viral vectors.

Eurogentec, in collaboration with a research team including a Nobel Laureate (In-Cell-Art), has developed new classes of vectors organized at the nanometric scale, that enable to cross efficiently and safely the cell barrier.